Filing Flows › Aspen Aerogels (ASPN) › Capital expenditures
Aspen Aerogels (ASPN) capital expenditures by quarter
Aspen Aerogels' capital expenditures were $1.4M in Q1 2026 (first quarter 2026), -43% from Q4 2025. Over the last 4 quarters it ranged from $1.4M (Q1 2026) to $13.0M (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | $1.4M | -43% | -89% |
| Q4 2025 | $2.5M | -73% | — |
| Q3 2025 | $9.1M | -30% | — |
| Q1 2025 | $13.0M | — | — |
Q1 2026 at a glance
Aspen Aerogels, Q1 2026: revenue $37.9M (-52% year over year), operating margin -55.0%, net loss $23.7M, operating cash flow $34.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aspen Aerogels' capital expenditures?
Aspen Aerogels' capital expenditures were $1.4M in Q1 2026 (first quarter 2026), -43% from Q4 2025.
How has Aspen Aerogels' capital expenditures changed?
Over the last 4 quarters it ranged from $1.4M (Q1 2026) to $13.0M (Q1 2025).